Equity Profile

FMS

Fresenius Medical Care AG

Health CareHealth Care Services$11.8B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2023After Close9:00 AM EDT

Company Snapshot

Fresenius Medical Care AG is a leading provider of products and services for individuals with chronic kidney failure. Operating in the Health Care sector, the company plays a crucial role in delivering dialysis services and related products, making it a key player in the health care services industry.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well the company is managing its costs and revenues.

$0.50

Revenue

Revenue reflects the overall sales performance and growth of the company, which is vital for assessing its market position.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In the last quarter, Fresenius Medical Care reported an EPS of $0.17, slightly below the estimate of $0.18, resulting in a minor stock decline. The company did not provide specific revenue figures or guidance, leaving investors uncertain about future performance.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Fresenius Medical Care to report an EPS of $0.50 and revenue of $4.6 billion for Q2-2023, reflecting cautious optimism. The market is weighing the company's ability to recover from recent earnings misses and improve its financial outlook.

Bull Case

If Fresenius Medical Care beats EPS expectations and shows strong revenue growth, it could signal a turnaround in operational efficiency and market demand for its services.

Bear Case

Conversely, if the company misses its earnings and revenue targets again, it may raise concerns about its long-term growth prospects and operational challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.50

EPS is a critical measure of profitability and will indicate how well the company is managing its costs and revenues.

Revenue

$4.6B

Revenue reflects the overall sales performance and growth of the company, which is vital for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $0.50?

A beat on EPS would indicate improved profitability and could boost investor confidence after recent misses.

What revenue figures will the company report, and how do they compare to the $4.6 billion consensus?

Revenue performance is crucial for assessing the company's growth trajectory and market demand for its services.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a strong recovery in Fresenius Medical Care's operational performance, especially given the recent focus on chronic disease management.

Supporting Evidence

The company has historically shown resilience after earnings misses, often recovering in subsequent quarters.

Options pricing suggests a significant move is expected, indicating that investors are anticipating potential surprises.

Key Risk

If the company reports a significant improvement in operational metrics, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical for determining whether the company can recover from previous earnings disappointments.

Bull Confirmed If

An EPS of $0.53 or higher, coupled with revenue exceeding $4.9 billion, would confirm the bull case.

Bear Confirmed If

An EPS below $0.47 and revenue under $4.5 billion would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±24.84%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating heightened uncertainty around the earnings report.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius Medical Care beats expectations, history suggests the stock could rise, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical patterns indicating an average drop of around 1.23%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiencies or cost management strategies.
2Insights into patient volume trends and demand for dialysis services.
3Comments on competitive pressures in the health care services sector.
4Guidance on future revenue growth and profitability targets.
5Any new partnerships or innovations in treatment options.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well the company is managing its costs and revenues.

$0.50

Revenue

Revenue reflects the overall sales performance and growth of the company, which is vital for assessing its market position.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Fresenius Medical Care beats EPS expectations and shows strong revenue growth, it could signal a turnaround in operational efficiency and market demand for its services.

Bear Case

Conversely, if the company misses its earnings and revenue targets again, it may raise concerns about its long-term growth prospects and operational challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.50

EPS is a critical measure of profitability and will indicate how well the company is managing its costs and revenues.

Revenue

$4.6B

Revenue reflects the overall sales performance and growth of the company, which is vital for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $0.50?

A beat on EPS would indicate improved profitability and could boost investor confidence after recent misses.

What revenue figures will the company report, and how do they compare to the $4.6 billion consensus?

Revenue performance is crucial for assessing the company's growth trajectory and market demand for its services.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a strong recovery in Fresenius Medical Care's operational performance, especially given the recent focus on chronic disease management.

Supporting Evidence

The company has historically shown resilience after earnings misses, often recovering in subsequent quarters.

Options pricing suggests a significant move is expected, indicating that investors are anticipating potential surprises.

Key Risk

If the company reports a significant improvement in operational metrics, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical for determining whether the company can recover from previous earnings disappointments.

Bull Confirmed If

An EPS of $0.53 or higher, coupled with revenue exceeding $4.9 billion, would confirm the bull case.

Bear Confirmed If

An EPS below $0.47 and revenue under $4.5 billion would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±24.84%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating heightened uncertainty around the earnings report.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius Medical Care beats expectations, history suggests the stock could rise, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical patterns indicating an average drop of around 1.23%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiencies or cost management strategies.
2Insights into patient volume trends and demand for dialysis services.
3Comments on competitive pressures in the health care services sector.
4Guidance on future revenue growth and profitability targets.
5Any new partnerships or innovations in treatment options.